Tenderwize
Retour à la recherche

Accord de remise pour solution buvable de propranolol

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Nov 27, 2027 · 371 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Propranolol (ATC-Code: C07AA05) in der Darreichungsform Lösung zum Einnehmen.

55/100

Score d'opportunité

Needs reviewHigh complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

55 / 100

Complexité

68 / 100

Facteurs de risque

The non-exclusive open-house model provides no stated volume or exclusivity commitment, and no estimated value is avail...

AOK may replace the open-house arrangement with exclusive rebate contracts; existing open-house contracts may then end...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Nov 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Supply-related rebate agreement for medicinal products containing propranolol, ATC code C07AA05, in oral solution form.
  • Non-exclusive open-house model with uniform contractual conditions and no individual negotiations.
Afficher le résumé complet

AOK Niedersachsen offers a non-exclusive open-house rebate agreement for oral propranolol solution (ATC C07AA05) in Germany. Eligible pharmaceutical entrepreneurs may join on uniform, non-negotiable terms without a selection decision. The agreement can start on 1 February 2026, may be joined on the first day of each month, and ends no later than 31 January 2028. The arrangement may terminate earlier if exclusive rebate contracts enter into force. Procurement documents and submission details must be requested from AOK; they were not provided for analysis.

Risques

The non-exclusive open-house model provides no stated volume or exclusivity commitment, and no estimated value is avail...

AOK may replace the open-house arrangement with exclusive rebate contracts; existing open-house contracts may then end...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The agreement is available only to pharmaceutical entrepreneurs within the meaning of Section 4(18) AMG, or a contractual group of such entrepreneurs, in relation to the...
  • The pharmaceutical entrepreneur must have its registered seat in Germany, another EU Member State, or another EEA contracting state for medicinal products marketed within the...
  • Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the offered medicinal products.

Critères d'attribution

Lot 1

Price is identified as the award criterion; no description or weighting is provided.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive propranolol rebate agreement

Non-exclusive open-house rebate agreement under Section 130a(8) SGB V for medicinal products containing propranolol in oral solution form. Contracts are available to all interested eligible pharmaceutical companies under identical conditions, without individual negotiation. The agreement may be replaced by exclusive contracts and may then end automatically.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Jan 2026 - Jan 2028

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Nov 27, 2027

Détails de la procédure

Date de publication
26 Nov 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
789069-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy